(Add quota, details)
PARIS, Jan 29 (Reuters) – If a new high – quality and virulent vaccine is found to be of high quality, European health authorities should review its use. they could have no “bias” about its origins, the psychologist who coordinated France ‘s vaccination strategy said on Friday.
Alain Fischer made the comments on BFM television after asking them about Hungary agreeing to buy doses of the Chinese company Sinopharm vaccine in addition to doses of Russian vaccine.
“All the vaccines need to be looked at. We can have no bias about the origin of vaccines. If vaccines show that they are safe, effective, have good quality products, and that they can eventually be introduced at European level, why not use them? They just have to meet those requirements, ”said Fischer.
Fischer also said it would be a “real mistake” to delay the roll-out of the current vaccine program in France if the government decides on a third lock-in.
Health Minister Olivier Veran said on Thursday that new versions of the coronavirus were circulating more widely every week and that a stricter curfew that had been applied nearly two weeks ago in France had not prevented the spread of the disease. virus. (Reporting by Dominique Vidalon and Geert de Clercq, Editing by Timothy Heritage)